China’s WuXi Biologics to sell vaccine facility to Merck for US$500 million
WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company ...
WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company ...
MODERNA reported a surprise third-quarter profit on Thursday (Nov 7), driven by cost cutting and higher-than-expected sales of its Covid-19 ...
A screenshot of an alleged CNN headline has made a new claim about US vice President kamala Harris. The screenshot ...
Hillchol utilises a single, genetically engineered inactivated strain delivered that significantly reduces production costsHILLEMAN Laboratories and Indian drugmaker Bharat Biotech ...
Hillchol utilises a single, genetically engineered inactivated strain that significantly reduces production costsHILLEMAN Laboratories and Indian drugmaker Bharat Biotech have ...
Sweden has reported its first case of mpox, a day after the World Health Organization (WHO) declared the infection a ...
MODERNA on Thursday (Aug 1) cut its 2024 sales forecast for Covid-19 and respiratory syncytial virus vaccines by up to ...
The US government has awarded US$176 million to Moderna to advance development of its bird flu vaccine, the company said ...
Sanofi and Novavax signed a licensing agreement that includes commercialising a combined Covid-19 and flu shot. Novavax will receive US$500 million ...
ASTRAZENECA said on Tuesday (May 7) it had initiated the worldwide withdrawal of its Covid-19 vaccine due to a “surplus ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.